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Abstract
Background Declines in skeletal muscle structure and function are found in various clinical populations, but the intramuscu-
lar proteolytic pathways that govern declines in these individuals remain relatively poorly understood. The nematode
Caenorhabditis elegans has been developed into a model for identifying and understanding these pathways. Recently, it
was reported that UNC-105/degenerin channel activation produced muscle protein degradation via an unknown mechanism.
Methods Generation of transgenic and double mutant C. elegans, RNAi, and drug treatments were utilized to assess molec-
ular events governing protein degradation. Western blots were used to measure protein content. Cationic dyes and adenosine
triphosphate (ATP) production assays were utilized to measure mitochondrial function.
Results unc-105 gain-of-function mutants display aberrant muscle protein degradation and a movement defect; both are re-
duced in intragenic revertants and in let-2mutants that gate the hyperactive UNC-105 channel. Degradation is not suppressed
by interventions suppressing proteasome-mediated, autophagy-mediated, or calpain-mediated degradation nor by suppres-
sors of degenerin-induced neurodegeneration. Protein degradation, but not the movement defect, is decreased by treatment
with caspase inhibitors or RNAi against ced-3 or ced-4. Adult unc-105 muscles display a time-dependent fragmentation of the
mitochondrial reticulum that is associated with impaired mitochondrial membrane potential and that correlates with de-
creased rates of maximal ATP production. Reduced levels of CED-4, which is sufﬁcient to activate CED-3 in vitro, are observed
in unc-105 mitochondrial isolations.
Conclusions Constitutive cationic inﬂux into muscle appears to cause caspase degradation of cytosolic proteins as the result
of mitochondrial dysfunction, which may be relevant to ageing and sarcopenia.
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Background
Maintained muscle protein homeostasis (proteostasis) occurs
through intricate regulation of balanced rates of protein syn-
thesis and degradation. Proteostasis is required to maintain
contractile ability and muscle as a metabolic reservoir.1
Declines in skeletal muscle mass, structure and function are
associated with ageing (sarcopenia), cancer (cachexia), COPD,
heart failure, and diabetes,2 but the proteolytic pathways
that govern declines in each of these conditions remain rela-
tively poorly understood.
Caenorhabditis elegans is an established laboratory animal
in which genetics and genomics can be used to understand
physiology and is the animal for which we know the most
about genes controlling muscle protein degradation.3 In C.
elegans muscle, increased trafﬁc to the proteasomes is
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normally prevented by neuronal release of acetylcholine4 to
presumably affect intramuscular calcium signalling5 and ap-
pears to occur in response to starvation,6 denervation,4 and
neurodegeneration.7 Increased trafﬁc to lysosomes via au-
tophagy is controlled by a balance of constitutive ﬁbroblast
growth factor and insulin/insulin like growth factor8; roughly
two dozen other protein kinases appear to oppose autopha-
gic degradation.9 These signals converge, modulating activa-
tion of autophagy via mitogen-activated protein kinase
(MAPK),10 and appear relevant to a model of neurodegener-
ation11 and to ageing.12 Lastly, calpains are activated in re-
sponse to muscle attachment complex disruption, which
appears required to maintain muscle in response to use.13,14
Recently, unc-105 gain-of-function mutants were reported
to display increased muscle protein degradation via an
unknown mechanism.5 unc-105 encodes a putative
mechano-sensitive ion channel of the ENaC/degenerin fam-
ily.15 ENaC/Degenerin channels are implicated in the patho-
physiology of some human neurodegenerative diseases,16
and hyperactivity of other ENaC/Degenerin channels causes
necrotic-like neuronal cell death in C. elegans.17–20 Domi-
nant gain-of-function mutations in unc-105 have previously
been shown to cause worms to be small, hypercontracted,
and paralyzed.21 These phenotypes are suppressed in unc-
105; let-2 double mutants.15 LET-2 is an alpha-2 type IV
basement membrane collagen22 that has been proposed
to physically gate the mutationally activated UNC-105 channel
in the muscle plasma membrane and thereby relieve the
anomalous ion inﬂux and rescue the aforementioned
phenotypes.15,23
Here, we report that unc-105 mutants but not unc-105;
let-2 double mutants display caspase-dependent muscle
protein degradation and loss of normal muscle mitochon-
drial architecture, mitochondrial membrane potential, and
maximal mitochondrial ATP production capacity. These
changes are associated with decreased mitochondrial-
associated CED-4. CED-4, or cell death abnormal protein
4, is the C. elegans orthologue of mammalian apoptotic
protease activating factor 1 (APAF1) and in vitro CED-4 is
sufﬁcient to activate the caspase CED-3. The discovery of
CED-3-mediated and CED-4-mediated programmed cell
death in C. elegans was the subject of the 2002 Nobel Prize
in Physiology or Medicine as programmed cell death is now
known to be crucial for regulating cell number. Indeed, lack
of proper activation of cell death is associated with cancer,
autoimmune disease, and neurodegenerative disease.
Collectively, our data suggest that excessive cationic inﬂux
into muscle leads to pathological changes in mitochondrial
architecture and function, and subsequent caspase activa-
tion. These data also complete our preliminary understand-
ing of the regulation of activation and increased trafﬁcking
to the four major proteolytic systems in C. elegans muscle,
and enable direct testing of the relevance of all four
systems to various (patho)physiologic conditions.
Materials and methods
Strains and culture
Strains of C. elegans were handled, maintained, and age-
synchronized as described.6 RNAi was as described13 using
sequence-veriﬁed RNAi (Source BioScience LifeSciences
Ltd.). Strains for protein degradation, maximal rates of ATP
production, and mitochondrial membrane potential assays
are as follows: PD55: ccls55 V, CC10: unc-105(n490) II; ccls55
V, and CC7: unc-105(n490) II; ccls55 V, lon-2(e678) let-2(n821)
X. Strains for Mitotracker® and Caspase 3/7 substrate assays
are as follows: CB5600: ccls4251 (myo-3::Ngfp-lacZ, myo-3::
Mtgfp) I; him-8(e1489) IV, CC62: ccls4251 (myo-3::Ngfp-lacZ,
myo-3::Mtgfp) I; unc-105(n490) II; him-8(e1489) IV and
CC63: ccls4251 (myo-3::Ngfp-lacZ, myo-3::Mtgfp) I; unc-105
(n490) II; him-8(e1489) IV; lon-2(e678) let-2(n821) X.
Mitochondrial function
MitoTracker® chloromethyl-X-rosamine (CMXRos) in vivo ac-
cumulation assay. Synchronized worms were grown to early
adulthood. Twenty animals per trial were processed as de-
scribed in 4.7μM CMXRos.24
JC-10 in vivo accumulation assay. Synchronized worms
were grown from the L1 stage in the presence of 83μM
JC-10 (Enzo Life Sciences, NY, USA).
JC-1 Fluorescence-activated cell sorting (FACS). Animals
were cultured and mitochondria isolated as described.14
Mitochondria were incubated in the dark for 15min at 37°C
in 20μM glutamate, 2mM malate, 6μM JC-1 (Invitrogen, UK).
Mitochondria were centrifuged (10 000 g, 5min), resuspended,
and sorted in a Beckman Coulter FC500 ﬂow cytometer
(Ex 490 nm and Em 605 nm). Loss of JC-1 in response to
loss of membrane potential was conﬁrmed by addition of
1μM CCCP.
Maximal rates of ATP production (MRAP). Maximal rates of
ATP production (MRAP) were assessed as described.14 Mixed-
stage populations were used to obtain sufﬁcient quantity of
mitochondria as unc-105mutants are very sick, taking at least
2–3weeks to produce a population capable of exhausting
food supplies on a plate.
Western blotting
β-Galactosidase westerns were performed as described13
with quantiﬁcation in Image J. CED-4,25 cytochrome C,26
and ATP-synthase27 antibodies were previously validated.
Anti-CED-4 (Santa Cruz Biotechnology, USA), was used at a
1:100 dilution in 5% milk TBS-T with secondary (Santa Cruz
Biotechnology, USA) at a 1:10 000 dilution. Anti-cytochrome
C and anti-ATP-synthase (anti-ATP5A) (Abcam®, UK) were
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used at a 1:1000 and 1:2500 dilution in 3% milk TBS, respec-
tively, with secondary (Sigma-Aldrich®, USA) at a 1:10 000
dilution.
Measurements of caspase activation
Synchronized adult worms were grown in the presence of
200μM Z-DEVD-ProRed™ (AAT Bioquest, UK) at 20°C and
analysed at t = 0, 12, 24, and 48 h with red ﬂuorescence noted
at all three later time points. For quantiﬁcation of caspase ac-
tivity, untreated animals were washed from single plates, ho-
mogenized in buffer containing 1% Triton, incubated with the
caspase reagent buffer (Caspase-Glo® 3/7 Assay Kit, Promega,
UK) for 45min at 37°C, and luminescence measured. Activity
is expressed versus a standard curve of titrated recombinant
human caspase 3 (Promokine, Germany).
Assessment of β-galactosidase activity
Animals were stained for β-galactosidase activity as de-
scribed.6 Control animals (PD55) or unc-105 (CC10 on stan-
dard Escherichia coli strain OP50 in the RNAi conditions)
were utilized.
Whole genome sequencing
Genomic DNA was prepared as described28 and sequenced
using Illumina Solexa GAII (BC Cancer Agency Genomic
Sciences Centre). Sequences were aligned to C.elegans genome
versionWS200 using Burrows-Wheeler Aligner (BWA)29 under
default settings. Resulting BAM ﬁles were processed to iden-
tify single nucleotide variants (SNVs) and small insertions
or deletions (indels) using VarScan.30 Variants were matched
to WS200 annotation using CooVar31 and categorized as
‘nonsense’, ‘missense’, ‘synonymous’, ‘non-coding’, ‘frame
preserving indel’, or ‘frame shifting indel’. Non-coding
mutations were deﬁned based upon intron and intergenic
regions. Only homozygous mutations (a mutation with more
than 90% read support for the change) were considered.
Movement assays
Movement was measured as described.10
Microscopy and statistics
Microscopy. All images were captured as described.13 Image
analysis and ﬁgure preparation was conducted in GIMP and
Photoshop.
Statistical analysis. All data are presented as means ± SEM
from at least three replicates unless otherwise stated. Statis-
tical differences were assessed using either one-way ANOVA
with Newman–Keuls corrections or two-way ANOVA with
Bonferroni corrections. Signiﬁcance was determined as
P< 0.05, and all statistics were completed using GraphPad
Prism (USA).
Results
Activation of UNC-105 causes muscle protein
degradation
Recently, it was reported that UNC-105 activation appears to
cause muscle protein degradation that is not suppressed by
treatment with proteasome inhibitors.5 The time dependent
loss of a transgenic β-galactosidase reporter protein’s activity
suggests that muscle protein degradation is occurring
(Figure 1A). This transgenic reporter protein has been shown
to be fully stable in muscle of well fed adult worms for at
least 72–96 h post-adulthood but is degraded upon activation
of various proteolytic systems.6,8,13 To conﬁrm that loss of en-
zymatic activity was due to degradation, we performed west-
ern blots (Figure 1B and C). RNAi against unc-105 in wild-type
animals had no effect on proteostasis,5 while the dominant
gain-of-function allele n490 caused protein degradation
(Figure 1); these observations suggest that it is the activation
of the UNC-105 ion channel that induces muscle protein deg-
radation. In support of this suggestion, we found that RNAi
against unc-105 attenuates the loss of β-galactosidase activity
in unc-105(n490) mutants (Figure 1D).
Previous work has shown that excessive Na+ inﬂux in mu-
tants containing another dominant gain-of-function mutation
in unc-105, n506, causes sustained muscle depolarisation that
is attenuated in unc-105(n506) mutants containing a second
mutation in let-2.23 LET-2 is an alpha-2 type IV basement
membrane collagen22 and treatment of unc-105; let-2 double
mutants with collagenase restores high levels of Na+ inﬂux.
These past results suggest that LET-2 has a physical interac-
tion with UNC-105, which gates the channel.23 Therefore, to
further test if UNC-105 activation leads to increased muscle
protein degradation, we tested if protein degradation was
suppressed in unc-105(n490); let-2(n821) double mutants.
As shown in Figure 1, protein degradation was suppressed
in unc-105; let-2 double mutants, further suggesting that hy-
peractivity of the UNC-105 channel causes muscle protein
degradation.
While conducting this work, two spontaneous mutants that
resulted in increased population growth rates in the unc-105
(n490) strain were isolated; designated as xg1 and xg2 (Figure
S1). xg1mutants display reduced muscle protein degradation,
while xg2 mutants do not (Figure 1). As unc-105 mutants pick
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up suppressing mutations at a high rate,32 we presumed that
xg1 and xg2might be mutations in known suppressing genes.
Previously identiﬁed suppressors of unc-105 include muta-
tions in unc-15, unc-22, unc-54, unc-96, crt-1, let-2, and unc-
105 itself15,19,32–34; these genes encode paramyosin, twitchin,
myosin heavy chain A, a Lin11, Isl-1 & Mec-3 (LIM) domain
containing protein that localizes to M-lines, calreticulin, a
collagen, and a degenerin channel, respectively. Because xg1
looked wild-type and the most frequently isolated mutation
that suppresses unc-105 with a wild-type appearance was
unc-105,32,33 we presumed that xg1 might be an intragenic
revertant. Similarly, as xg2 visibly twitched and unc-22 is the
only isolated suppressor that twitches,32 we presumed that
xg2 might be an allele of unc-22. Full genome sequencing
(Figure S2, Table 1, Dataset S1) conﬁrmed a 4bp insertion
unc-105 at II: 8118943 in the strain containing xg1 and a non-
sense mutation disrupted unc-22 at IV: 11984751 in the strain
containing xg2. RNAi against unc-105 or unc-22 produces the
same effect on β-galactosidase activity in unc-105(n490)
mutants (Figure 1D) as does allele xg1 or xg2 (Figure 1A). In
the intragenic revertant, xg1, a premature stop codon is
predicted, like RNAi against unc-105, to reduce the abundance
of UNC-105. The decreased abundance of activated UNC-105
presumably results in less Na+ inﬂux, which suggests that
hyperactivation of the channel causesmuscle protein degradation.
Muscle protein degradation in response to UNC-
105 activation is distinct from previously described
mechanisms
As unc-105, other degenerin channels, and muscle protein
degradation have all previously been studied in C. elegans,
we were curious if other known suppressors of unc-105
gain-of-function, mutations that reduce neuronal cell death
in response to hyperactivity of other ENaC/Degenerin
channels,17–19,35 and/or suppression of previously identiﬁed
proteolytic pathways could attenuate the protein degrada-
tion induced by UNC-105 activation (Figure 2A). RNAi against
unc-15, unc-96, and crt-1 each also failed to suppress the
protein degradation observed in unc-105 gain-of-function
mutants (Figure 2B). The failure to suppress degradation
was not simply as the result of ineffective RNAi as RNAi
against crt-1 improved the movement defect in unc-105
gain-of-function mutants (Figure 3), as expected.19 RNAi
against itr-1, asp-3, asp-4, asp-6, cnx-1, mec-6, or unc-68, also
each failed to block protein degradation (Figure 2D); these
genes encode the following: inositol trisphosphate receptor,
three aspartyl proteases, calnexin, a degenerin channel sub-
unit, and ryanodine receptor. Lastly, as shown in Figure 2C,
protein degradation in response to UNC-105 activation is
not suppressed by treatment with proteasome inhibitor,
Table 1 Summary of single nucleotide variations and indels in strains CC24 (containing xg1) and CC50 (containing xg2)
Strain Synonymous Silent Missense Nonsense Frame-preserving indel Frame-shifting indel
CC24 4 47 4 1 0 2
CC50 1 20 2 1 0 0
Figure 1 Activation of UNC-105 causes protein degradation in muscle. Synchronized young adults were used (t = 0 h), and all experiments repeated
at least three times. (A) Representative stains for β-galactosidase at t = 72 h post-adulthood; scale bar represents 100 μm. (B) Representative west-
ern blots of β-galactosidase in 30-worm lysates. Arrows show β-galactosidase fusion protein at 146 kD. Wild-type controls are not included as unc-
105; let-2 results are not signiﬁcantly different from published wild-type values.4,8,10,13 (C) Kinetics of β-galactosidase degradation, quantiﬁed from
three independent western blots. * denotes P< 0.05; ** denotes P< 0.01; *** denotes P< 0.001 between unc-105 and unc-105; let-2, two-way
repeated measures ANOVA with Bonferroni correction. (D) Representative stains for β-galactosidase at t = 72 h post-adulthood; scale bar repre-
sents 100 μm.
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calpain inhibitor or RNAi against calpains, or by RNAi against
mpk-1 that acts to control autophagic degradation.
Caspases are activated in response to UNC-105
activation
Having determined that degradation did not appear to be protea-
some, autophagy, or calpain based, we wished to determine if
degradation was due to activation of caspases. While the activa-
tion of caspases has been shown in terminally differentiatedmam-
malian cells,36 this has not been an area of much study in C.
elegans and caspase activation in ageing C.elegans muscle was
only recently demonstrated.37 RNAi against either of the execu-
tioner caspases, ced-3 or csp-1, attenuated protein degradation
in unc-105mutants (Figure 4A). Similarly, unc-105mutants treated
with caspase inhibitors (Quinolyl-Valine-Aspartic acid (QVD),
Acetyl-Aspartic acid-Glutamic acid-Valine-Aspartic acid (ADEVD),
and Acetyl-Aspartic acid- Methionine - Glutamine -Aspartic acid
(ADMQD)) displayed reduced degradation (Figure 4A). Lastly, as
CED-3 exists as an inactive zymogen that is activated upon binding
to CED-4 in vitro,38 we conﬁrmed that RNAi against ced-4 also at-
tenuated degradation (Figure 4A). Together, these results suggest
that caspases are necessary for the increased protein degradation
observed in response to UNC-105 activation.We conﬁrmed signif-
icantly greater caspase activity in unc-105 mutants versus wild-
type and unc-105; let-2 mutants (Figure 4B). To conﬁrm caspase
activation speciﬁcally in muscles, we fed worms a caspase sub-
strate that exhibits red ﬂuorescence upon cleavage. No ﬂuores-
cence was observed outside of the gut in wild-type or unc-105;
let-2 mutants, whereas red ﬂuorescence was observed in tissue
(s) outside of the gut in unc-105 mutants (Figure 4C). Next, we
Figure 2 UNC-105-induced protein degradation is not suppressed by known suppressors of protein degradation or neurodegeneration in
Caenorhabditis elegans. Synchronized young adults were used (t = 0 h), and all experiments repeated at least three times. Representative stains
for β-galactosidase at t = 72 h post-adulthood; scale bar represents 100 μm. (A) Untreated unc-105 mutants. (B) RNAi against known suppressors
of unc-105 growth or movement defect. (C) RNAi or drugs targeting known components of calpain,13 proteasome,4,6 or autophagic8,10 muscle pro-
tein degradation in C. elegans. (D) RNAi against known suppressors of MEC-4 degenerin-induced neuronal degeneration.
Figure 3 Caspase inhibition does not markedly restore the movement
defect in unc-105 mutants. Synchronized young adults were used
(t = 0 h), and all experiments repeated at least three times. Movement
of the head back and forth in liquid was determined for 10 adults each
assessed 10 times. *** denotes P< 0.001, two-way ANOVA with
Bonferroni correction.
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used worms containing Green Fluorescent Protein (GFP)
expressed only in body wall muscles and found unc-105, but not
unc-105; let-2 mutants display yellow/orange ﬂuorescence, as
the result of red and green ﬂuorescence in the same tissue, in
body wall muscles when fed the ﬂuorescent caspase substrate
(Figure 4D); note that yellow/orange ﬂuorescence was not noted
in all muscle cells at any individual time point, possibly reﬂective
of inter-muscle differences in caspase substrate uptake and/or
degradation. Collectively, these results suggest that caspases are
activated in body wall muscles in response to UNC-105 activation
and account for the increased muscle protein degradation.
Blocking protein degradation does not
substantially restore the movement defect in unc-
105 mutants
Since reducing caspase levels or activity attenuated the
protein degradation observed in unc-105 mutants, we
tested if these treatments, like let-2, also attenuated the
movement defect. We conﬁrmed that unc-105 mutants
have a signiﬁcant reduction in movement in comparison
with wild-type animals at young adulthood21 and that this
is substantially rescued in unc-105; let-2 double mutants15
(Figure 3). However, a caspase inhibitor (ADEVD) had no ef-
fect, and ced-3 RNAi had only a small positive effect on
movement in unc-105 mutants (Figure 3). These results
combined with the observations that crt-1 RNAi rescues
the movement defect but does not prevent protein degra-
dation, suggest that caspase activation in unc-105 mutants
is occurring at least somewhat independently of the move-
ment defect.
Activation of UNC-105 causes fragmentation of the
mitochondrial network in muscle
CED-4 binds to and activates CED-3 in vitro,38 and inactive
CED-4 has been suggested to be localized to mitochondria.39
Figure 4 Caspases are activated in muscles of unc-105 mutants. Synchronized young adults were used (t = 0 h), and all experiments repeated at
least three times, for (B) seven independent experiments. (A) Representative stains for β-galactosidase at t = 72 h post-adulthood in unc-105 mu-
tants either untreated or treated with RNAi or drugs targeting caspases; scale bar represents 100 μm. (B) In vitro caspase 3 assay. * denotes
P< 0.05 between unc-105 and wild-type; *** denotes P< 0.001 between unc-105 and unc-105; let-2; one-way ANOVA with Newman–Keuls
correction. (C) Representative images of a ﬂuorescent caspase 3 indicator substrate, Z-DEVD-ProRed™, from t = 24 h adult animals; scale bar repre-
sents 50 μm. (D) Representative images of a ﬂuorescent caspase 3 indicator substrate, Z-DEVD-ProRed™, from t = 24 h adult animals expressing GFP
localized to the mitochondria and nuclei of muscle; scale bar represents 25 μm, and the enlarged regions are an additional 2.5× magniﬁcation. Note
that the GFP and red substrate combine to produce yellow/orange colour in muscle when viewed using a triple pass ﬁlter.
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Structural damage to mitochondria occurs in HEK cells
overexpressing UNC-10540 and excess Na+ inﬂux causes func-
tional damage to mitochondria in mammalian muscle.41
Thus, because ced-4 RNAi blocked degradation (Figure 4A),
we wanted to determine if mitochondria were damaged
in response to UNC-105 activation. As shown in Figure 5A,
unc-105 mutants display time-dependent fragmentation
of the mitochondrial network in adult muscle. This
fragmentation is prevented by RNAi against unc-105 and
in unc-105; let-2 double mutants (Figure 5A), which sug-
gests that it is UNC-105 hyperactivation that is causing
the fragmentation.
UNC-105 activation impairs maintenance of the
mitochondrial membrane potential
We wanted to determine if the mitochondrial disturbance
was purely structural or also functional. Mitotracker® Red
CMXRos is a mitochondrial dye that accumulates within
mitochondria dependent upon mitochondrial membrane
potential. The accumulation of Mitotracker® Red CMXRos
is reduced in unc-105 but not in unc-105; let-2 double mu-
tants (Figure 5B), suggesting that activation of UNC-105
results in an inability to maintain mitochondrial membrane
potential. However, because Mitotracker® requires a nor-
mal plasma membrane potential in order to accumulate
in mitochondria and unc-105 mutants have an altered
membrane potential,23 it is possible that some or all of
the reduced accumulation could be due to limited entry
into muscle. Therefore, we used JC-10, another dye that
both accumulates and exits mitochondria dependent upon
the mitochondrial membrane potential, thereby allowing
assessment of the loss of mitochondrial membrane poten-
tial with time. When grown in the presence of JC-10,
unc-105 mutants display accumulation of JC-10 in muscle
mitochondria at adulthood, with loss of JC-10 over time
(Figure 5C). These results suggest that UNC-105 activation
causes a time-dependent fragmentation of the mitochon-
drial reticulum and concomitant failure to maintain the
mitochondrial membrane potential. To conﬁrm and quan-
tify the extent of this impairment of the mitochondrial
membrane potential and determine whether it was main-
tained ex vivo, we performed ﬂuorescence activated cell
sorting of isolated mitochondria from wild-type, unc-105,
and unc-105; let-2 double mutants. In the top quartile of
isolated mitochondria displaying JC-1 accumulation in the
presence of glutamate and malate, mitochondria from
unc-105 mutants display 25% less of the potential-
dependent dye JC-1 than wild-type or unc-105; let-2
animals (Figure 5D). These results further suggest impaired
mitochondrial membrane potential in response to UNC-105
activation.
Activation of UNC-105 causes a depression in the
maximal mitochondrial rate of ATP production
Inability to maintain mitochondrial membrane potential will
lead to declines in mitochondrial ATP production as the
result of a decrease in the proton gradient that drives H+
through ATP synthase. Thus, we measured the maximal rate
of ATP production (MRAP) in isolated mitochondria. For all
substrate combinations, the mean MRAP was reduced in
mitochondria isolated from unc-105 mutants versus wild-
type, and this reduction was signiﬁcant for all substrates ex-
cept glutamate + malate and pyruvate + malate (Figure 5E).
Similarly, for all substrate combinations the reduction in
mean MRAP in unc-105 mutants was attenuated in mito-
chondria isolated from unc-105; let-2 double mutants, which
was signiﬁcant in all cases except glutamate + succinate
(Figure 5E). Because MRAP is signiﬁcantly depressed in
unc-105 mutants, we determined whether glycolytic ATP
production increased as a compensatory adaptation to main-
tain cellular total ATP production. We ﬁnd no increase in
maximal Phosphofructokinase (PFK) activity in unc-105
(Figure S3), which suggests metabolic compensation via
non-mitochondrial ATP production is not occurring.
Speciﬁc mitochondrial proteins are decreased in
mitochondria extracted from unc-105 mutants
Having determined that mitochondria appear damaged in
response to UNC-105 activation, we tested if, as predicted
by ced-4-dependent and ced-3-dependent cytosolic muscle
protein degradation, less CED-4 is associated with mito-
chondria following UNC-105 activation. Mitochondria
isolated from unc-105 mutants contain less CED-4 and cyto-
chrome C compared with the amount present in mitochon-
dria isolated from wild-type or unc-105; let-2 double
mutants (Figure 6). Given the reduced MRAP in unc-105
mutants, we also examined the amount of ATP synthase.
There is no comparable decline in ATP synthase in mito-
chondria isolated from unc-105 mutants (Figure 6A), which
conﬁrms that reductions do not simply represent unequal
loading of samples and suggests that decreased levels of
CED-4 and cytochrome C are not simply random loss of
mitochondrial proteins in response to UNC-105 activation.
This observation appears to be consistent with the recent
suggestion of a mitochondrial transition pore in C. elegans
muscle.42 Additionally, our ﬁnding of less CED-4 and
cytochrome C associated with damaged mitochondria adds
weight to the suggestion that CED-4/CED-3 dependent
apoptosis, which is independent of a requirement of
cytochrome C in C. elegans, reﬂects evolution of a lack of
cytochrome C dependence in C. elegans versus evolutionary
ancestors.43
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Figure 5 Mitochondria are dysfunctional in unc-105mutants. All experiments were repeated at least three times, for (D) seven and (E) 10 indepen-
dent experiments. (A–C) Synchronized young adults were used (t = 0 h); scale bars represent 25 μm and enlarged regions an additional 2.5× mag-
niﬁcation. (A) Strains containing GFP localized to mitochondria and nuclei in muscle were used to assess mitochondrial architecture. (B) Strains
containing GFP localized to mitochondria and nuclei in muscle were used to assess mitochondrial membrane potential speciﬁcally in muscle. Ac-
cumulation of Mitotracker® CMXRos in mitochondria in muscle as indicated both by yellow/orange mitochondria and green mitochondria in muscle
post-photobleaching. Displayed images are for t = 0 h young adults. (C) Worms were grown in the presence of JC-10 to assess in vivo loss of mito-
chondrial membrane potential. (D) Loss of membrane potential was conﬁrmed in vitro in unc-105 mutants when mitochondria were isolated from
mixed populations of all three stains and were sorted using ﬂuorescence-activated cell sorting and JC-1. Displayed are the percent of mitochondria
showing the highest quartile of accumulation of JC-1 as indicated by the extent of red ﬂuorescence. (E) Measurement of maximal ATP production
rates (MRAP). Displayed are data for mitochondria isolated from n = 250300 mixed stage animals per sample. Substrate combinations were (G + S)
glutamate and succinate; (G +M) glutamate and malate (Pal +M) palmitoyl-L-carnitine and malate; (Py +M) pyruvate and malate and (S) succinate.
Data are expressed as a ratio to maximal citrate synthase (CS) activity; the standard marker of mitochondrial content. *P< 0.05; **P< 0.01;
***P< 0.001; one-way ANOVA and Newman–Keuls correction.
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Discussion
Mitochondrial dysfunction and caspase activation
in UNC-105 mutants
We have shown that unc-105 but not unc-105; let-2 double
mutants display fragmentation of mitochondrial networks in
muscle, decreased mitochondrial membrane potential, de-
creased maximal rates of mitochondrial ATP production, and
reduced levels of cytochrome C and CED-4 in extracted mito-
chondria. Because the second mutation in let-2 relieves cat-
ionic inﬂux in unc-105 mutants,23 these results suggest that
activation of UNC-105 and consequent cationic inﬂux into C.
elegans muscle results in damage to mitochondrial structure
and function in vivo. Additionally, because unc-105 but not
unc-105; let-2 double mutants display both caspase activation
and pathological degradation of cytosolic muscle protein that
is mediated by caspases, it appears that that activation of
UNC-105 and consequent cationic inﬂux into C. elegans mus-
cle results in activation of caspases in muscle cytosol in vivo.
As CED-4 is sufﬁcient to activate the CED-3 caspase
in vitro,38 the ﬁndings of less CED-4 in mitochondria extracted
from unc-105 but not unc-105; let-2 double mutants and RNAi
against ced-4 attenuating degradation in unc-105 mutants,
suggest that the pathological degradation in the muscle cyto-
sol and the mitochondrial damage in unc-105 mutants are
causally linked by translocation of CED-4 away from damaged
mitochondria to cause activated CED-3 to be present in the cy-
tosol. Combined, our data suggest a model (Figure 7) whereby
cationic inﬂux through activated UNC-105 results in mitochon-
drial damage, CED-4 translocation away from damaged mito-
chondria, CED-4 activation of CED-3, and subsequent
pathological degradation of proteins in the muscle cytosol.
Whole genome sequencing combined with
subtractive analysis enables prospective studies of
evolution in C.elegans
We used whole genome sequencing combined with subtrac-
tive analysis to identify two spontaneous mutants. We have
conﬁrmed the identity of the suppressing mutations both
by known phenotypes of past suppressing mutations and by
use of RNAi against each putative suppressor to phenocopy
suppression of unc-105 phenotypes. Given the ability to per-
form RNAi against every gene in the genome of C. elegans,
whole genome sequencing combined with subtractive analy-
sis and RNAi against a single or handful of genes identiﬁed
provides a rapid way of identifying and conﬁrming suppress-
ing mutations of physiologic interest.
C.elegans as a model for studying genetic
regulation of muscle protein degradation
Past studies have established C. elegans as a model in which ge-
netics and genomics can be used to uncover the regulation of
muscle protein degradation and revealed regulatory signals
governing proteasomes, autophagy, and calpains.3 The present
study now completes our preliminary picture of signals that reg-
ulate each of the four major proteolytic systems in C. elegans
Figure 6 Less CED-4 and cytochrome C are associated with mitochon-
dria extracted from unc-105 mutants. All experiments were conducted
at least three times. Mitochondria extracted from wild-type, unc-105,
and unc-105; let-2 double mutants were examined for mitochondrial
protein content; n = 250300 mixed stage animals per sample. (A) Rep-
resentative western blots for CED-4, cytochrome C, and ATP synthase.
(B) Quantiﬁcation of CED-4 levels as a percentage of ATP synthase
levels, n = 3. (C) Quantiﬁcation of cytochrome C levels as a percentage
of ATP synthase levels, n = 3. *P< 0.05; **P< 0.01, one-way ANOVA
with Newman–Keuls correction.
Degenerin channel activation in muscle 189
Journal of Cachexia, Sarcopenia and Muscle 2016; 7: 181–192
DOI: 10.1002/jcsm.12040
muscle. Combined, these studies enable future exploration of
the relevance of these regulatory and proteolytic systems to dif-
ferent physiologic, pathophysiologic, or disease states.
Relevance of mitochondrial dysfunction and muscle
protein degradation to sarcopenia
Mitochondrial dysfunction has been suggested to be a hall-
mark of ageing. The observations that unc-105 mutants dis-
play disrupted sarcomeres, a movement defect, premature
muscle protein degradation, and mitochondrial fragmenta-
tion and decline collectively suggest that unc-105 mutants
may be a model of accelerated ageing (progeria). This has
previously been suggested for another mutant that displays
mitochondrial dysfunction.44 Cellular degeneration of muscle
appears to be similar to that of nerves in that both appear to
be a disease of age, and there is fragmentation of mitochon-
drial networks in response to neuronal degeneration45,46 and
in ageing muscle.13,46 These observations coupled with the
fact that C. elegans is an accepted model for studying age-
ing47 and sarcopenia48 suggest that future study of the role
of muscle mitochondrial dysfunction and muscle protein deg-
radation in the onset and/or progression of sarcopenia can
now be achieved using C. elegans. Accordingly, it is intriguing
to note that caspase activation and consequent myosin deg-
radation in ageing C. elegans muscle have recently been
reported.37
Sodium channel, non-voltage gated 1 alpha subunit
(SCNN1A) is a human orthologue of UNC-105 and is
expressed in human skeletal muscle (http://www.
proteinatlas.org/). Given that APAF1, caspases, and mito-
chondria are all also expressed in human skeletal muscle,
there is signiﬁcant scope for our ﬁnding of excessive sodium
inﬂux into C. elegans muscle leading to mitochondrial
dysfunction and caspase activation (Figure 7) to be rele-
vant to human muscle function and/or pathology. If
SCNN1A is mechanosensitive in human skeletal muscle,
then like mechanosensitive calcium channels, it may
contribute to ionic imbalance in response to stretch and
in individuals with muscular dystrophy.49 Given that cyto-
skeletal proteins are common targets of caspases, there
is a reason to suspect that any ionic imbalance resulting
from SCNN1A hyperactivation would lead to cytoskeletal
remodelling and/or dystrophy; therefore, the role of
SCNN1A in human skeletal muscle would seem to warrant
further investigation. Similarly, if a past report of de-
creased chloride transport and mitochondrial function
with age in human muscle is correct,50 then altered ionic
balance may lead to both altered mitochondrial function
and cytoskeletal alterations via loss of mitochondrial
membrane potential and caspase activation with age,
another area that would seem to warrant further investi-
gation. As previously noted,50 altered mitochondrial func-
tion with age in human muscle, as opposed to C. elegans
muscle, might be an adaptation rather than a simple path
to eventual cellular demise.
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